https://www.selleckchem.com/pr....oducts/puromycin-ami
The study aimed to recruit approximately 200 participants, including patients diagnosed with dementia or Parkinson disease, caregivers, socio-health professionals, and other stakeholders, from five different European countries Germany, Italy, Portugal, Romania, and Spain. The study took place between April and September 2020. Recruitment is now closed, and all the data have been collected and analyzed in order to be used in shaping the large-scale pilot phase of the PROCare4Life project. Results of the study are expect
Gefällt mir
Kommentar
Teilen
